Skip to main content

Industrial Microbiology Market is expected to grow at a CAGR of 8.36%

 The capability of genetically engineered cells to make new products revolutionized the processes of industrial microbiology. Techniques like gene mounting and genetic engineering have helped the fermentation industry with enhanced productivity. The use of bioprocesses helped the industries to deliver fine-quality products. The application of industrial microbiology is currently expanding in areas such as therapeutics, diagnostics, environmental protection, mineral recovery, and agriculture, apart from its traditional application in the food and beverage industry.

The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030, witnessing a CAGR of 8.36% during the forecast period 2020-2030. The market growth can mainly be attributed to the growing research in the field of industrial microbiology, increasing awareness among researchers about new strains of microorganisms, rise in preference toward consumer products, increase in research and development as well as collaborations in pharmaceutical and biotechnology industries, and use of rapid sterility testing methods for pathogen detection.

The global industrial microbiology market is currently dominated by Thermo Fisher Scientific, followed by bioMérieux SA. The market dominance of Thermo Fisher Scientific can be attributed to a large product portfolio for automated microbial detection systems. bioMérieux SA held the second largest market share in the industrial microbiology market, attributed to its significant contribution in the field. The company offers a wide range of products to be utilized for industrial procedures in the biopharmaceutical, food and beverages, and water industry. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, detection kits, and accessories) and detection systems. Other prominent players, namely, 3M, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Pall/Danaher Corporation, Merck KGaA, and Eppendorf, collectively hold a large market share of the total global industrial microbiology market in 2019.

Based on region, North America is the leading contributor to the industrial microbiology market in terms of revenue. The fields such as commercial quality assurance and biotechnology & pharmaceutical companies are expected to progress at significant rates, and the substantial investments made in these fields are consequentially promoting the growth of the North America industrial microbiology market. However, the Asia-Pacific and Europe regions, constituting several emerging companies contributing to industrial microbiology, are expected to register the high CAGR during the forecast period of 2020-2030.

Request  a Sample - https://bisresearch.com/requestsample?id=1074&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more